ADMA
ADMA Biologics Inc
NASDAQ: ADMA · HEALTHCARE · BIOTECHNOLOGY
$10.60
-2.75% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
17.67
P/S ratio
4.83x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$7 – $24
Volume
6.8M
ADMA Biologics Inc (ADMA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $1.12M | $3.07M | $5.92M | $7.18M | $10.66M | $22.76M | $16.99M | $29.35M | $42.22M | $80.94M | $154.08M | $258.21M | $426.45M | $510.17M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | +174.4% | +92.8% | +21.3% | +48.5% | +113.5% | -25.4% | +72.8% | +43.9% | +91.7% | +90.4% | +67.6% | +65.2% | +19.6% |
| Cost of revenue | — | — | — | — | — | — | $669056.00 | $2.02M | $3.74M | $4.31M | $6.36M | $29.16M | $42.19M | $39.50M | $61.29M | $79.77M | $118.81M | $169.27M | $206.90M | $217.41M |
| Gross profit | — | — | — | — | — | — | $449062.00 | $1.04M | $2.17M | $2.87M | $4.30M | $-6.40M | $-25.21M | $-10.16M | $-19.07M | $1.17M | $35.27M | $88.94M | $219.55M | $292.76M |
| Gross margin | — | — | — | — | — | — | 40.2% | 34.0% | 36.7% | 39.9% | 40.3% | -28.1% | -148.4% | -34.6% | -45.2% | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% |
| R&D | — | — | — | — | — | — | $3.47M | $9.30M | $9.52M | $7.02M | $7.69M | $6.23M | $3.93M | $2.34M | $5.91M | $3.65M | $3.61M | $3.30M | $1.81M | $4.76M |
| SG&A | — | $24000.00 | — | $20530.00 | $20530.00 | $26464.00 | $3.14M | $4.37M | $4.82M | $6.75M | $8.49M | $18.09M | $22.50M | $25.91M | $35.05M | $55.19M | $70.30M | $57.38M | $74.12M | $91.58M |
| Operating income | $-29.69M | $-29.69M | $-24.89M | $-20.01M | $-20530.00 | $-26464.00 | $-7.91M | $-15.04M | $-16.02M | $-15.51M | $-17.33M | $-39.31M | $-60.29M | $-41.42M | $-64.91M | $-58.37M | $-39.37M | $21.63M | $138.98M | $191.44M |
| Operating margin | — | — | — | — | — | — | -707.4% | -490.4% | -270.8% | -216.1% | -162.6% | -172.7% | -354.9% | -141.1% | -153.8% | -72.1% | -25.5% | 8.4% | 32.6% | 37.5% |
| EBITDA | — | $-29.69M | $-24.89M | $-20.01M | $-20526.00 | $-26460.00 | $-7.71M | $-14.70M | $-15.83M | $-15.66M | $-16.81M | $-39.31M | $-56.77M | $-36.03M | $-59.82M | $-53.09M | $-39.51M | $5.12M | $147.69M | $197.86M |
| EBITDA margin | — | — | — | — | — | — | -689.2% | -479.2% | -267.6% | -218.1% | -157.6% | -172.7% | -334.3% | -122.8% | -141.7% | -65.6% | -25.6% | 2.0% | 34.6% | 38.8% |
| EBIT | $-29.69M | $-29.69M | $-24.89M | $-20.01M | $-20530.00 | $-26464.00 | $-7.89M | $-14.91M | $-16.08M | $-16.13M | $-17.28M | $-40.54M | $-60.22M | $-39.29M | $-63.76M | $-58.59M | $-46.63M | $-3.21M | $139.64M | $189.77M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $30683.00 | $618225.00 | $1.29M | $1.84M | $2.24M | $3.29M | $5.52M | $8.99M | $11.99M | $13.06M | $19.28M | $25.03M | $13.93M | $7.11M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-29.69M | $-29.69M | $-24.89M | $-20.01M | $-20526.00 | $-26460.00 | $-7.30M | $-15.53M | $-16.81M | $-17.97M | $-19.52M | $-43.76M | $-65.74M | $-48.28M | $-75.75M | $-71.65M | $-65.90M | $-28.24M | $197.67M | $146.93M |
| Net income growth (YoY) | — | +0.0% | +16.2% | +19.6% | +99.9% | -28.9% | -27493.8% | -112.7% | -8.3% | -6.9% | -8.6% | -124.2% | -50.2% | +26.6% | -56.9% | +5.4% | +8.0% | +57.2% | +800.0% | -25.7% |
| Profit margin | — | — | — | — | — | — | -653.0% | -506.2% | -284.2% | -250.4% | -183.1% | -192.3% | -387.1% | -164.5% | -179.4% | -88.5% | -42.8% | -10.9% | 46.4% | 28.8% |